Authors/Disclosures
|
|
No disclosure on file |
|
Jorge G. Ortiz-Garcia, MD, FAAN
(The University of Oklahoma Health Sciences Center)
|
Dr. Ortiz-Garcia has nothing to disclose. |
|
|
No disclosure on file |
|
Karen D. Orjuela, MD, FAAN
(University of Colorado - Anschutz Medical Center)
|
The institution of Dr. Orjuela has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. Dr. Orjuela has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Orjuela has received research support from Abbott. The institution of Dr. Orjuela has received research support from NIH . The institution of Dr. Orjuela has received research support from Bristol Myers Squibb Foundation. The institution of Dr. Orjuela has received research support from American Heart Association and Bristol Myers Squibb Foundation. |
|
|
No disclosure on file |
|
Rochelle T. Sweis, DO
|
No disclosure on file |
|
|
No disclosure on file |
|
Jose Biller, MD, FACP, FAHA, FAAN
(Loyola University Stritch School of Medicine)
|
Dr. Biller has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwer. Dr. Biller has received publishing royalties from a publication relating to health care. |
|
Robert C. Green, MD, MPH
(Division of Genetics)
|
No disclosure on file |
|
Walter Kremers
|
The institution of Walter Kremers has received research support from NIH. The institution of an immediate family member of Walter Kremers has received research support from NIH. |
|
Lindsay A. Farrer, MD
(Boston Univ School of Medicine)
|
No disclosure on file |
|
Charles S. DeCarli, MD, FAAN
(UC Davis Health - Dept of NeurologyAlzheimer's Disease Research Center)
|
Dr. DeCarli has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novo Nordisk. The institution of Dr. DeCarli has received research support from NIH. |